1. Home
  2. RGS vs PLRX Comparison

RGS vs PLRX Comparison

Compare RGS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$29.00

Market Cap

68.7M

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.12

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGS
PLRX
Founded
1922
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.7M
70.6M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
RGS
PLRX
Price
$29.00
$1.12
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.67
AVG Volume (30 Days)
4.4K
620.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
20.24
29.97
EPS
0.89
N/A
Revenue
$210,134,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.02
N/A
Revenue Growth
3.52
N/A
52 Week Low
$18.23
$1.08
52 Week High
$31.50
$1.95

Technical Indicators

Market Signals
Indicator
RGS
PLRX
Relative Strength Index (RSI) 62.29 44.15
Support Level $28.97 N/A
Resistance Level $30.04 $1.37
Average True Range (ATR) 0.77 0.05
MACD 0.14 -0.00
Stochastic Oscillator 100.00 35.00

Price Performance

Historical Comparison
RGS
PLRX

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: